298 related articles for article (PubMed ID: 30772490)
1. Quantitative label-free mass spectrometry using contralateral and adjacent breast tissues reveal differentially expressed proteins and their predicted impacts on pathways and cellular functions in breast cancer.
Gomig THB; Cavalli IJ; Souza RLR; Vieira E; Lucena ACR; Batista M; Machado KC; Marchini FK; Marchi FA; Lima RS; de Andrade Urban C; Cavalli LR; Ribeiro EMSF
J Proteomics; 2019 May; 199():1-14. PubMed ID: 30772490
[TBL] [Abstract][Full Text] [Related]
2. High-throughput mass spectrometry and bioinformatics analysis of breast cancer proteomic data.
Gomig THB; Cavalli IJ; Souza RLR; Lucena ACR; Batista M; Machado KC; Marchini FK; Marchi FA; Lima RS; Urban CA; Cavalli LR; Ribeiro EMSF
Data Brief; 2019 Aug; 25():104125. PubMed ID: 31294064
[TBL] [Abstract][Full Text] [Related]
3. Proteomic profiling of infiltrating ductal carcinoma reveals increased cellular interactions with tissue microenvironment.
Gormley M; Tchafa A; Meng R; Zhong Z; Quong AA
J Proteome Res; 2012 Apr; 11(4):2236-46. PubMed ID: 22356716
[TBL] [Abstract][Full Text] [Related]
4. Comparative serum proteome analysis of human lymph node negative/positive invasive ductal carcinoma of the breast and benign breast disease controls via label-free semiquantitative shotgun technology.
Hu X; Zhang Y; Zhang A; Li Y; Zhu Z; Shao Z; Zeng R; Xu LX
OMICS; 2009 Aug; 13(4):291-300. PubMed ID: 19624269
[TBL] [Abstract][Full Text] [Related]
5. Proteomic analysis of infiltrating ductal carcinoma tissues by coupled 2-D DIGE/MS/MS analysis.
Davalieva K; Kiprijanovska S; Broussard C; Petrusevska G; Efremov GD
Mol Biol (Mosk); 2012; 46(3):469-80. PubMed ID: 22888636
[TBL] [Abstract][Full Text] [Related]
6. Multipronged quantitative proteomics reveals serum proteome alterations in breast cancer intrinsic subtypes.
Gajbhiye A; Dabhi R; Taunk K; Jagadeeshaprasad MG; RoyChoudhury S; Mane A; Bayatigeri S; Chaudhury K; Santra MK; Rapole S
J Proteomics; 2017 Jun; 163():1-13. PubMed ID: 28495502
[TBL] [Abstract][Full Text] [Related]
7. Mass spectrometric characterization of protein structure details refines the proteome signature for invasive ductal breast carcinoma.
Röwer C; Koy C; Hecker M; Reimer T; Gerber B; Thiesen HJ; Glocker MO
J Am Soc Mass Spectrom; 2011 Mar; 22(3):440-56. PubMed ID: 21472563
[TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis of breast cancer tissues to identify biomarker candidates by gel-assisted digestion and label-free quantification methods using LC-MS/MS.
Song MN; Moon PG; Lee JE; Na M; Kang W; Chae YS; Park JY; Park H; Baek MC
Arch Pharm Res; 2012 Oct; 35(10):1839-47. PubMed ID: 23139137
[TBL] [Abstract][Full Text] [Related]
9. Proteomic Analysis of Urine to Identify Breast Cancer Biomarker Candidates Using a Label-Free LC-MS/MS Approach.
Beretov J; Wasinger VC; Millar EK; Schwartz P; Graham PH; Li Y
PLoS One; 2015; 10(11):e0141876. PubMed ID: 26544852
[TBL] [Abstract][Full Text] [Related]
10. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
[TBL] [Abstract][Full Text] [Related]
11. Proteomic analysis in human breast cancer: identification of a characteristic protein expression profile of malignant breast epithelium.
Hudelist G; Singer CF; Pischinger KI; Kaserer K; Manavi M; Kubista E; Czerwenka KF
Proteomics; 2006 Mar; 6(6):1989-2002. PubMed ID: 16470630
[TBL] [Abstract][Full Text] [Related]
12. Integrated analysis of label-free quantitative proteomics and bioinformatics reveal insights into signaling pathways in male breast cancer.
Gomig THB; Gontarski AM; Cavalli IJ; Souza RLR; Lucena ACR; Batista M; Machado KC; Marchini FK; Marchi FA; Lima RS; Urban CA; Marchi RD; Cavalli LR; Ribeiro EMSF
Genet Mol Biol; 2021; 44(1):e20190410. PubMed ID: 33656060
[TBL] [Abstract][Full Text] [Related]
13. Efficient isolation and quantitative proteomic analysis of cancer cell plasma membrane proteins for identification of metastasis-associated cell surface markers.
Lund R; Leth-Larsen R; Jensen ON; Ditzel HJ
J Proteome Res; 2009 Jun; 8(6):3078-90. PubMed ID: 19341246
[TBL] [Abstract][Full Text] [Related]
14. Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis.
Lai TC; Chou HC; Chen YW; Lee TR; Chan HT; Shen HH; Lee WT; Lin ST; Lu YC; Wu CL; Chan HL
J Proteome Res; 2010 Mar; 9(3):1302-22. PubMed ID: 20052998
[TBL] [Abstract][Full Text] [Related]
15. In situ proteomic analysis of human breast cancer epithelial cells using laser capture microdissection: annotation by protein set enrichment analysis and gene ontology.
Cha S; Imielinski MB; Rejtar T; Richardson EA; Thakur D; Sgroi DC; Karger BL
Mol Cell Proteomics; 2010 Nov; 9(11):2529-44. PubMed ID: 20739354
[TBL] [Abstract][Full Text] [Related]
16. Comparative proteomics of primary breast carcinomas and lymph node metastases outlining markers of tumor invasion.
Milioli HH; Santos Sousa K; Kaviski R; Dos Santos Oliveira NC; De Andrade Urban C; De Lima RS; Cavalli IJ; De Souza Fonseca Ribeiro EM
Cancer Genomics Proteomics; 2015; 12(2):89-101. PubMed ID: 25770193
[TBL] [Abstract][Full Text] [Related]
17. High-throughput proteomic analysis of human infiltrating ductal carcinoma of the breast.
Somiari RI; Sullivan A; Russell S; Somiari S; Hu H; Jordan R; George A; Katenhusen R; Buchowiecka A; Arciero C; Brzeski H; Hooke J; Shriver C
Proteomics; 2003 Oct; 3(10):1863-73. PubMed ID: 14625848
[TBL] [Abstract][Full Text] [Related]
18. Proteomic approach reveals FKBP4 and S100A9 as potential prediction markers of therapeutic response to neoadjuvant chemotherapy in patients with breast cancer.
Yang WS; Moon HG; Kim HS; Choi EJ; Yu MH; Noh DY; Lee C
J Proteome Res; 2012 Feb; 11(2):1078-88. PubMed ID: 22074005
[TBL] [Abstract][Full Text] [Related]
19. Comparative proteomic analysis of different stages of breast cancer tissues using ultra high performance liquid chromatography tandem mass spectrometer.
Al-Wajeeh AS; Salhimi SM; Al-Mansoub MA; Khalid IA; Harvey TM; Latiff A; Ismail MN
PLoS One; 2020; 15(1):e0227404. PubMed ID: 31945087
[TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
